Consistent with the microtubule‐targeting activity of VU‐0365114, cancer cells with higher levels of mitotic regulators (CDK1, CCNB1, and STMN1) were more sensitive to VU‐0365114 (Table 1, Fig. 9A). This evidence concerns the gene CDK1 and cancer.